With the ever changing evolution of the gig economy, many industries have had to adjust to meet the demands of the market to continue to ensure that they were still hiring top talents, that goes for industries like Pharma and Biotech. As outlined in this Pharma Exec article published this year, Pharma has been considered the employer of choice for a long time, an industry where many employees would jumpstart their careers as they sought the opportunity to grow within a company or move comfortably to another industry employer.
With the ever changing evolution of the gig economy, many industries have had to adjust to meet the demands of the market to continue to ensure that they were still hiring top talents, that goes for industries like Pharma and Biotech. As outlined in this Pharma Exec article published this year, Pharma has been considered the employer of choice for a long time, an industry where many employees would jumpstart their careers as they sought the opportunity to grow within a company or move comfortably to another industry employer.
This venture-backed, clinical stage company is developing novel delivery approaches to cell therapy. Their lead product is being developed to treat Acute Kidney Injury (AKI), the sudden loss of kidney function that can occur following cardiac surgery.
Clora has worked on 3 projects with this company relating to the filing of their IND and the execution of their early stage clinical programs.
However, when it comes to bringing these new therapies to market quickly and efficiently, there is ample room for all of us in this industry to do better.
Subscribe now and receive a box filled with hand-picked awesome items